Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -1.05% | 87.30 | 1.3% | $1275.26m | |
| AMGN | Amgen Inc. | -0.25% | 198.89 | 1.2% | $667.61m | |
| GILD | Gilead Sciences, Inc. | -1.28% | 67.64 | 0.9% | $577.79m | |
| BIIB | Biogen Inc. | -1.63% | 332.03 | 1.3% | $485.41m | |
| LOXO | Loxo Oncology Inc | -0.18% | 233.26 | 12.7% | $449.60m | |
| ILMN | Illumina, Inc. | 0.05% | 305.63 | 3.5% | $350.96m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.28% | 186.15 | 1.9% | $318.23m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.12% | 404.54 | 2.6% | $308.69m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.03% | 111.70 | 2.0% | $229.47m | |
| TSRO | TESARO, Inc. | 0.03% | 74.88 | 14.4% | $201.67m | |
| A | Agilent Technologies, Inc. | -0.82% | 70.02 | 1.5% | $164.25m | |
| EXAS | Exact Sciences Corporation | -2.75% | 74.97 | 25.3% | $151.07m | |
| INCY | Incyte Corporation | -2.79% | 76.56 | 2.5% | $146.84m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.45% | 119.26 | 15.4% | $142.24m | |
| LGND | Ligand Pharmaceuticals Incorporated | -16.48% | 110.05 | 23.1% | $105.44m |
Company Profile
TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.